机器人辅助肾部分切除术后显著eGFR下降的列线图预测模型
本研究基于多中心数据库999例接受机器人辅助肾部分切除术的患者,构建列线图预测术后3至15个月内eGFR较基线下降≥25%的风险。模型纳入年龄、性别、Charlson合并症指数、基线eGFR、RENAL评分及急性肾损伤状态,内部验证C指数为73%,校准良好,决策曲线分析显示概率≥4%时有净获益。
要点
- 列线图可预测RAPN术后3–15个月显著eGFR下降(≥25%)。
- 术后急性肾损伤(无论基线肾功能正常或CKD)是显著预测因子。
- 模型内部验证C指数73%,校准良好,决策曲线分析有净获益。
核心结论
- 构建的列线图能准确预测RAPN术后显著eGFR下降,有助于早期识别高风险患者。
研究设计与样本
- 多中心数据库回顾性研究,共纳入999例接受机器人辅助肾部分切除术的患者。
- 采用Cox生存函数构建列线图,预测术后3至15个月内eGFR较基线下降≥25%的风险。
- 内部验证采用留一交叉验证,并通过Schönfeld检验评估比例风险假设。
主要发现
- 146例患者发生显著eGFR下降,幸存者中位随访时间为12.4个月。
- 术后15个月显著eGFR下降的概率为19%。
- 基线肾功能正常患者发生AKI的HR为4.51(95%CI 3.12–6.60,p<0.001)。
- CKD患者发生AKI的HR为4.90(95%CI 2.17–11.1,p<0.001)。
- 内部验证C指数为73%,校准曲线显示校准良好,决策曲线分析显示概率≥4%时有净获益。
关键数值与推荐
- 显著eGFR下降定义为较基线下降≥25%。
- AKI定义为从术前至出院时eGFR下降>25%。
- 列线图纳入变量:年龄、性别、Charlson合并症指数、基线eGFR、RENAL肾测量评分、基线肾功能正常患者的AKI、CKD患者的AKI。
- 所有变量均为显著eGFR下降的预测因子(所有p≤0.048)。
临床怎么用
- 可用于RAPN术后早期识别肾功能显著下降的高危患者,指导术后监测与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decreased functional outcome after partial nephrectomy is associated with overall mortality. OBJECTIVE: To create a model that predicts ≥25% reduction from baseline estimated glomerular filtration rate (eGFR) in patients undergoing robot-assisted partial nephrectomy (RAPN) and to investigate the role of acute kidney injury (AKI) in this patient population. DESIGN, SETTING, AND PARTICIPANTS: A total of 999 patients were identified from a multi-institutional database. Renal function was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for chronic kidney disease (CKD). AKI was defined as >25% reduction in eGFR from pre-RAPN period to discharge. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: A nomogram to predict significant eGFR reduction (≥25% from baseline) in the time-frame between 3 and 15mo after RAPN was built based on the coefficients of Cox survival function that ultimately included age, sex, Charlson comorbidity index, baseline eGFR, RENAL nephrometry score, AKI in patients with normal baseline renal function, and AKI on CKD. Such landmark analysis was chosen in order to account for eGFR fluctuations occurring within the first 3mo of RAPN. The proportional hazard assumption was evaluated through the Schönfeld test. Internal validation was performed using the leave-one-out cross validation. Calibration was graphically investigated. The decision curve analysis (DCA) was used to evaluate the net clinical benefit. RESULTS AND LIMITATIONS: Median (interquartile range [IQR]) age at surgery was 61yr (51, 68). Overall, 146 patients experienced significant eGFR reduction; median follow-up for survivors was 12.4mo. The 15-mo probability of significant eGFR reduction was 19%. All variables fitted into the model, including AKI in patients with normal renal function (hazard ratio [HR]: 4.51; 95% confidence interval [CI]: 3.12, 6.60; p<0.001) and AKI on CKD (HR: 4.90; 95% CI: 2.17, 11.1; p<0.001), emerged as predictors of significant eGFR reduction (all p≤0.048) and were considered to build a nomogram. The internally validated c index was 73%. The model demonstrated excellent calibration and a net benefit at the DCA with probabilities ≥4%. CONCLUSIONS: We developed a nomogram that accurately predicts significant eGFR reduction after RAPN. This model may serve as a tool for early identification of patients at high risk for significant renal function decline after surgery. PATIENT SUMMARY: We have developed a model for the prediction of renal function loss after partial nephrectomy for renal cancer.
引用
- Martini A, Cumarasamy S, Beksac AT, et al. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy. Eur Urol. 2018. PMID: 30224195. doi:10.1016/j.eururo.2018.08.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。